Results 141 to 150 of about 1,766 (198)

Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease. [PDF]

J Clin Pathol
Nishikori A, Nishimura MF, Fajgenbaum DC, Nishimura Y, Maehama K, Haratake T, Tabata T, Kawano M, Nakamura N, Momose S, Sumiyoshi R, Koga T, Yamamoto H, van Rhee F, Kawakami A, Sato Y.   +15 more
europepmc   +1 more source

IgG4-positive cell infiltration in various cardiovascular disorders - results from histopathological analysis of surgical samples [PDF]

, 2017
Hideki Ozawa, Koichi Sohmiya, Masaaki Hoshiga, Masahiro Daimon, Nobukazu Ishizaka, Ryoto Hourai, Satomi Kasashima, Shu-ichi Fujita, Takahiro Katsumata, Yasuhiro Ogino, Yohei Yamauchi, Yoshinobu Hirose   +11 more
core   +1 more source

Curative Gastrectomy for Advanced Gastric Cancer in a Patient with Idiopathic Multicentric Castleman Disease: A Rare Case Report. [PDF]

Surg Case Rep
Kawabata R, Ushimaru Y, Hara H, Takeoka T, Yasuhara Y, Yoshihara T, Kitagawa A, Takeda T, Tomihara H, Naito A, Murakami M, Noura S, Miyamoto A.   +12 more
europepmc   +1 more source

A Phase Ib Investigator-Initiated Trial of Filgotinib in Patients With Idiopathic Multicentric Castleman Disease. [PDF]

Cureus
Fukui S, Sumiyoshi R, Koga T, Hosogaya N, Narita S, Morimoto S, Yano H, Katsube A, Yano S, Masaki Y, Tsunoda S, Sato S, Migita K, Matsuyama K, Kato N, Kawamoto A, Kawakami A.   +16 more
europepmc   +1 more source

A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients. [PDF]

Cureus
Koga T, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Yoshifuji H, Higa S, Kawakami A.   +8 more
europepmc   +1 more source

Update and new approaches in the treatment of Castleman disease [PDF]

core   +2 more sources

TAFRO subtype of idiopathic multicentric Castleman disease in a 22-year-old man. [PDF]

CMAJ
Rowe S, Collins BW, Pirzada A, Manning N, Chen LYC.   +4 more
europepmc   +1 more source

Prognostic value of serum C-reactive protein in idiopathic multicentric Castleman disease and construction of a prognostic model for patients. [PDF]

Front Med (Lausanne)
Lei Z, Wang Y, Yu T, Zhang Y, Cui W, Luo C, Luo Q, Zhou L, Gao Y, Yu L.   +9 more
europepmc   +1 more source

No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysis. [PDF]

Sci Rep
Miller I, Mumau MD, Shyamsundar S, Sarmiento Bustamante M, Horna P, Gonzalez MV, Fajgenbaum DC.   +6 more
europepmc   +1 more source

Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients. [PDF]

Front Immunol
Feng A, Gonzalez MV, Kalaycioglu M, Yin X, Mumau M, Shyamsundar S, Bustamante MS, Chang SE, Dhingra S, Dodig-Crnkovic T, Schwenk JM, Garg T, Yoshizaki K, van Rhee F, Fajgenbaum DC, Utz PJ.   +15 more
europepmc   +1 more source